If you're fortunate enough to have $10,000 sitting in your savings account and no immediate use for it, then it could be worth putting it to work in the share market.
After all, with a historic return in the region of 10%, that $10,000 could become $11,000 in 12 months if history were to repeat itself.
In addition, if you can find an ASX share with market-beating potential, then you could grow your wealth even more.
But which shares could do this? Could CSL Ltd (ASX: CSL) shares beat the market? Let's find out.
$10,000 invested in CSL shares
At present, the CSL share price is trading at $289.24. This means that if you were to invest $10,000 (and a further $123.40), you would end up owning 35 units.
According to a recent note out of Morgans, its analysts see scope for the company's shares to rise from current levels. The broker said:
While shares have struggled of late, we continue to view CSL as a key portfolio holding and sector pick, offering double-digit recovery in earnings growth as plasma collections increase, new products get approved and influenza vaccine uptake increases around ongoing concerns about respiratory viruses, with shares trading at 25x, a substantial discount (20%) to its long-term average.
Morgans has an add rating and $315.35 price target on CSL's shares. This implies potential upside of 9% and values those 35 units at $11,037.25.
Bigger returns
The good news is that even bigger returns could be on the cards according to analysts at Macquarie.
A recent note out of the investment bank reveals that its analysts have an outperform rating and $330.00 price target on the company's shares. This suggests that upside of 14.1% is possible over the next 12 months.
If this recommendation proves accurate, those 35 CSL shares would have a market value of $11,550. That's almost $1,500 greater than your original investment.
But it gets better. Macquarie is feeling very positive about the outlook of the CSL Behring business. This is particularly important given how it is far and away the biggest contributor to CSL's overall earnings.
As a result, the broker sees scope for CSL's shares to rise significantly over the next three years thanks to the strength of the CSL Behring business. So much so, it believes that a share price of $500 is possible by 2027.
If that happens, it would mean those 35 shares will be worth a sizeable $17,500. That's a very large increase on the original outlay of $10,123.40.
Here's hoping that Macquarie is on the money with its recommendation and valuation.
